AMANDA METZ: Open Payments
NPI 1548985385 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 37 payments from 14 companies in 2025. Trend: 2023 $1,329 · 2024 $1,013 · 2025 $759
Food & beverage: $669Education: $90
| Company | Payments | Amount |
|---|---|---|
| Evofem Biosciences, Inc. | 8 | $150 |
| Astellas Pharma US Inc | 3 | $125 |
| Sage Therapeutics, LLC | 5 | $105 |
| Sumitomo Pharma America, Inc. | 4 | $69 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $60 |
| Organon LLC | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $39 |
| ABBVIE INC. | 1 | $28 |
| Exeltis, USA Inc. | 1 | $23 |
Products named: Phexxi, ZURZUVAE, MYFEMBREE, NEXPLANON, Wegovy, Veozah, LINZESS, Mirena.
Industry payments across MO — which companies pay providers there.
